高胆固醇的斑马鱼饮食会促进高胆固醇血症和禁食相关的肝硬化症
Yang Jin1, Darby Kozan2, Eric D Young3
1Department of Embryology, Carnegie Institution for Science, Baltimore, MD, USA; Department of Animal and Aquacultural Sciences, Norwegian University of Life Sciences, Aas, Norway.
Journal of lipid research
|September 1, 2024
概括
斑马鱼的新高胆固醇饮食 (HCD) 协议有效地模拟了人类脂质障碍. 这种可靠的方法有助于研究脂肪肝疾病机制,通过跟踪随时间的脂质变化.
科学领域:
- 心血管研究研究心血管研究
- 代谢性疾病研究研究
- 斑马鱼作为一个模型生物体
背景情况:
- 脂质代谢研究经常使用动物模型.
- 标准化高胆固醇饮食 (HCD) 对于研究脂质疾病至关重要.
- 对于斑马鱼来说,一直缺乏统一的HCD协议.
研究的目的:
- 为斑马鱼开发和验证一个改进的HCD协议.
- 研究HCD对脂质沉积和脂蛋白调节的影响.
- 建立一个可靠的斑马鱼模型,用于脂质相关疾病.
主要方法:
- 开发并测试了一种针对斑马鱼的新型HCD协议.
- 评估了饮食的稳定性,可重复性和可口性.
- 分析了幼虫和成年鱼的脂质水平,脂蛋白 (ApoB-LPs) 和基因表达 (fasn).
主要成果:
- 食斑马鱼的HCD表现出高胆固醇血症,其中ApoB-LPs和胆固醇 Ester的水平升高.
- 幼虫HCD食诱导肝肥胖症,由禁食加剧.
- 成年鱼的ApoB-LPs升高和脂质生成基因上调,但脂肪肝不稳定.
结论:
- 开发的HCD斑马鱼协议对于研究饮食中的胆固醇影响是有效的.
- 这个模型提供了关于脂质代谢和脂肪肝疾病的时间动态的见解.
- 该协议为研究人类脂质相关疾病提供了一种可靠的方法.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Overview of Carbohydrate Metabolism
4.5K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
4.5K
Drug toxicity: Drug–Drug Interaction
437
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
437
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
958
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
958
Hypoglycemia and Glucagon
1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Atherosclerosis III: Management
747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747


